JOHNSON AND JOHNS DC JNJ (NYSE)

$ 66.21
17:40
Change: unch (unch%)
Volume: 15,476,866

Avg. Volume: 11852519
P/E Ratio: 15
EPS (Annual): 2.96
Profit Margin:
Dividend & Yield(Annual): 2.83%
Shares Outstanding: 2,818,190
Institutional Shareholders: 63.32%
Last: 66.21
Change: unch (unch%)
Prev. Close: 66.21
Open: 65.15
Day's Range: 65.15 - 66.28
52wk Range: 58.01 - 67.97
Market Value: 183,520,688
Beta: .38
12-month EPS Change: -18.01%
Total Return Last 12 Months: +9.45%
Total Return Last 3 Years: +9.97%
Total Return Last 5 Years: +46.87%
5-Year Revenue Growth Rate: 68.32%
5-Year Dividend Growth Rate: 74.19%
5-Year EPS Growth Rate: 66.51%


Headlines on JNJ

NJ to lose more than 800 pharmaceutical jobs

(TRENTON, N.J.)More than 800 pharmaceutical jobs will be leaving New Jersey starting in August. Most of the job cuts and transfers are part of major previously announced restructurings at Johnson...READ MORE
Jul 08, 2008 1:21PM
Keywords: JNJ, SGP, ABT

Cosmetics group spent $190,000 lobbying in 1Q

(WASHINGTON)The Personal Care Products Council spent $190,000 in the first quarter lobbying on funding for the Food and Drug Administration, according to a disclosure report.READ MORE
Jul 08, 2008 12:26PM
Keywords: JNJ, EL, KMB

FDA seeks suicide warning on anti-seizure drugs

(WASHINGTON)The Food and Drug Administration hopes to add its most serious warning label to epilepsy drugs, based on evidence they increase the risk of suicide in patients.READ MORE
Jul 07, 2008 3:57PM
Keywords: PFE, GSK, JNJ

Abbott rises after FDA approves Xience V stent

(NEW YORK)Shares of Abbott Laboratories rose Thursday after regulators approved its drug-coated Xience V stent for sale. The Food and Drug Administration approved the stent late Wednesday, a...READ MORE
Jul 03, 2008 10:37AM
Keywords: ABT, BSX, JNJ

Ahead of the Bell: Abbott Labs stent approved

(NEW YORK)Abbott Laboratories will reach its market share goals for its drug-coated Xience V stent, analysts said Thursday. The Food and Drug Administration approved the stent late Wednesday...READ MORE
Jul 03, 2008 7:57AM
Keywords: ABT, BSX, JNJ

Affymax wavers on forecast of Hematide approval

(NEW YORK)Shares of Affymax Inc. fluctuated wildly Wednesday after an analyst predicted success for the company's drug candidate Hematide as a treatment for anemia caused by kidney disease.READ MORE
Jul 02, 2008 5:39PM
Keywords: AFFY, AMGN, JNJ, NKTR

Abbott gets FDA approval for drug-coated stent

(NORTH CHICAGO, Ill.)Drug developer and medical device maker Abbott Laboratories said Wednesday it received Food and Drug Administration approval for its anticipated drug-coated stent, Xience V.READ MORE
Jul 02, 2008 5:36PM
Keywords: ABT, BSX, MDT, JNJ
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

PFIZER INC -27.40 18.19
MERCK CO INC -29.50 36.97
BRISTOL MYERS S -27.00 21.65
SCHERING PLOUGH -28.40 20.86
WYETH -0.90 49.48